Legal Representation
Attorney
Bruce W. Longbottom
USPTO Deadlines
Next Deadline
90 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
October 22, 2025
Extension Available
Until October 22, 2025
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 15, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 14, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 22, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 27, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 27, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 7, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 25, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 24, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 24, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 24, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 11, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 2, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations in tablet form for medicinal purposes, namely, for treatment of cancer, cardiovascular diseases, diabetes, kidney diseases and disorders, liver diseases and disorders, and obesity
Class 044
Medical information services; arranging and providing medical information services relating to pharmaceuticals, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Additional Information
Design Mark
The mark consists of the letter "L" in stylized form.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
LILLY
Classification
International Classes
005
044